Home > Keywords >
Catalog | name | Description | price |
---|---|---|---|
R-C-3129 | A-9758 CAS:2055271-22-0 | A-9758 is a RORγ ligand and a potent,selective RORγt inverse agonist (IC50=5nM),and exhibits robust potency against IL-17A release. | price> |
R-C-4119 | DPPE-polyethylene glycol550-SH | DPPE-PEG-SH,1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol-Thiol can be conjugated with peptides,antibodies,or proteins which contain Maleimide groups on the surface. | price> |
R-R-4799 | DMTr-LNA-U-3-CED-Phosphora CAS No.206055-76-7 | DMTr-LNA-U-3-CED-phosphora/CAS No.206055-76-7 is a phosphorite monomer that can be used in the synthesis of oligonucleotides. | price> |
R-C-3130 | SR3335 CAS:293753-05-6 | SR3335(ML 176)is a selective RORα inverse agonist that directly binds to RORα with a Ki of 220nM. Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4800 | Uridine 3,5-diphosphate CAS No.2922-95-4 | Uridine 3,5-diphosphate (3,5-UDP; Compound pUp)/CAS No.2922-95-4 is a competitive RNase inhibitor. | price> |
R-C-3131 | SR1001 CAS:1335106-03-0 | SR1001 is a selective ROR-alpha and ROR-gamma inverse agonist;suppresses TH17 cell differentiation and inhibits autoimmunity.Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4801 | Halofuginone hydrochloride CAS No.1217623-74-9 | Halofuginone (RU-19110) hydrobromid/CAS No.1217623-74-9, a Febrifugine derivative, is a competitive prolyl-tRNA synthetase inhibitor with a Ki of 18.3 nM. Halofuginone hydrobromid is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibition of TGF-β activity. Halofuginone hydrobromid is also a potent pulmonary vasodilator by activating Kv channels and blocking voltage-gated, receptor-operated and store-operated Ca2+ channels. Halofuginone hydrobromid has anti-malaria, anti-inflammatory, anti-cancer, anti-fibrosis effects. | price> |
R-C-3132 | Abarelix acetate CAS:183552-38-7 | Abarelix Acetate(PPI 149 Acetate;R 3827 Acetate)is a potent gonadotrophin-releasing hormone(GnRH)antagonist,used for prostate cancer research.Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4802 | Folic acid-d4 CAS No.171777-72-3 | Folic acid-d4/CAS No.171777-72-3 is the deuterium labeled Folic acid. Folic acid (Vitamin M; Vitamin B9) is a B vitamin; is necessary for the production and maintenance of new cells, for DNA synthesis and RNA synthesis. | price> |
R-C-3133 | NBI-42902 CAS :352290-60-9 | NBI-42902 is a novel nonpeptide antagonist of the human gonadotropin-releasing hormone receptor.Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4803 | 5-BrdUTP sodium salt CAS No.102212-99-7 | 5-BrdUTP sodium salt/CAS No.102212-99-7 is a TdT substrate which can be used to label the DNA double-strand breaks. | price> |
R-C-3134 | SR 144528 CAS:192703-06-3 | SR 144528 is a selective peripheral cannabinoid receptor inverse agonist that displays a Ki value of 0.6 nM for rat spleen and human recombinant CB2 receptors and a Ki value of 400 nM for rat brain and human recombinant CB1 receptors. Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4804 | Methotrexate a-tert-butyl ester CAS No.79640-70-3 | Methotrexate α-tert-butyl ester/CAS No.79640-70-3, capped by OtBu, significantly reduces tumor growth in HT1080 tumor bearing mice. Methotrexate is an antimetabolite and antifolate agent and is also an immunosuppressant and antineoplastic agent. | price> |
R-C-3135 | Ganirelix CAS:123246-29-7 | Ganirelix is an injectable competitive gonadotropin-releasing hormone antagonist (GnRH antagonist).Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4805 | DHODH-IN-8 CAS No.1148126-03-7 | DHODH-IN-8 (Compound 27)/CAS No.1148126-03-7 is an inhibitor of human and Plasmodium falciparum dihydroorotate dehydrogenase (DHODH) with IC50s of 0.13 μM and 47.4 μM, and Kis of 0.016 μM and 5.6 μM, respectively. DHODH-IN-8 has antimalarial activity. | price> |
R-C-3136 | Degarelix acetate CAS:934246-14-7 | Degarelix acetate is a gonadotropin releasing hormone(GnRH)receptor antagonist.Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4806 | Polyinosinic-polycytidylic acid CAS No.24939-03-5 | Polyinosinic-polycytidylic acid (Poly(I:C))/CAS No.24939-03-5 is a synthetic analog of double-stranded RNA and an agonist of toll-like receptor 3 (TLR3) and retinoic acid inducible gene I (RIG-I)-like receptors (RIG-I and MDA5). Polyinosinic-polycytidylic acid can be used as a vaccine adjuvant to enhance innate and adaptive immune responses, and to alter the tumor microenvironment. Polyinosinic-polycytidylic acid can directly trigger cancer cells to undergo apoptosis. | price> |
R-C-3137 | GHRP-6 Acetate CAS:87616-84-0 | GHRP-6 Acetate is a growth hormone releasing peptide.Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4807 | Tanespimycin CAS No.75747-14-7 | Tanespimycin (17-AAG)/CAS No.75747-14-7 is a potent HSP90 inhibitor with an IC50 of 5 nM, having 100-fold higher binding affinity for tumor cell-derived HSP90 than normal cell-derived HSP90. Tanespimycin depletes cellular STK38/NDR1 and reduces STK38 kinase activity. Tanespimycin also downregulates stk38 gene expression. | price> |
R-C-3138 | Elagolix sodium CAS:832720-36-2 | Elagolix is a Gonadotropin-Releasing Hormone(GnRH)Antagonist.Elagolix inhibits gonadatropin releasing hormone(GnRH)receptors in the pituitary gland and ultimately reduces circulating sex hormone levels.Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |